| 000 | 01719 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515012840.0 | ||
| 264 | 0 | _c20060705 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0020-1669 | ||
| 024 | 7 |
_a10.1021/ic051538e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTzanopoulou, Stamatia | |
| 245 | 0 | 0 |
_aOxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives. _h[electronic resource] |
| 260 |
_bInorganic chemistry _cJan 2006 |
||
| 300 |
_a902-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdiagnosis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xchemical synthesis |
| 650 | 0 | 4 |
_aOrganotechnetium Compounds _xchemical synthesis |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPhenols _xchemistry |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xchemical synthesis |
| 650 | 0 | 4 |
_aRhenium _xchemistry |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xchemistry |
| 650 | 0 | 4 |
_aTechnetium _xchemistry |
| 650 | 0 | 4 |
_aThiazoles _xchemistry |
| 700 | 1 | _aPirmettis, Ioannis C | |
| 700 | 1 | _aPatsis, Georgios | |
| 700 | 1 | _aRaptopoulou, Catherine | |
| 700 | 1 | _aTerzis, Aris | |
| 700 | 1 | _aPapadopoulos, Minas | |
| 700 | 1 | _aPelecanou, Maria | |
| 773 | 0 |
_tInorganic chemistry _gvol. 45 _gno. 2 _gp. 902-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/ic051538e _zAvailable from publisher's website |
| 999 |
_c16028295 _d16028295 |
||